Suggested Learning

QIVc vaccine available for 2019-20 flu service

Health organisations have informed pharmacists that the cell-grown quadrivalent vaccine (QIVc), known as Flucelvax Tetra, has been licensed for use and can be ordered for the 2019-20 flu vaccination service.

In a letter to contractors, NHS England, Public Health England and the Department of Health and Social Care said the vaccine, manufactured by Seqirus, was not available for the 2018-19 service but can be used in 2019-20.

QIVc is indicated for adults aged 18 to 64 years of age in clinical at-risk groups, including pregnant women or other eligible groups. It is also available for people aged 65 and over.

Vaccines available for the 2018-19 and 2019-20 flu season include the standard egg cultured quadrivalent inactivated vaccine (QIVe) for 18 to 64-year-olds in clinical at-risk groups and other eligible groups and adjuvanted trivalent inactivated vaccine (aTIV) for those aged 65 and over.

The PSNC said: “NHS England has determined that the high-dose trivalent vaccine (TIV-HD), which has also been granted licensed status, has a significantly higher list price and will therefore not be commissioned by NHS England or reimbursed for use in the flu vaccination service 2019/20.

“Contractors are therefore advised not to purchase or administer this product for the advanced flu vaccination service.”



Picture: Jovanmandic (iStock)

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.